Physician profile
James Cassuto
NPI 1750775912
$3,058.45
in general payments reported to CMS, 2019-2025
9 companies · $563 in 2025
The $563 reported for 2025 was more than what 80% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $37.18 · 2021: $53.03 · 2022: $33.86 · 2023: $15.00 · 2024: $2,356 · 2025: $563.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,873 · Food and Beverage: $1,062.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,872.62 |
| Food and Beverage | $1,061.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ge Healthcare | $2,238.90 | 2022-2025 | |
| Progenics Pharmaceuticals, INC. | $293.15 | 2025 | |
| Siemens Medical Solutions USA, INC. | $268.76 | 2024 | |
| Telix Pharmaceuticals | $59.09 | 2025 | Illuccix |
| Astellas Pharma US INC | $58.88 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $51.16 | 2021-2024 | |
| Pfizer INC. | $47.45 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.58 | 2025 | |
| Merck Sharp & Dohme LLC | $20.48 | 2024 | Keytruda |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Cassuto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.